Blood oxygenation was studied in patients undergoing cardiopulmonary bypass using the RyggKyvsgaard bubble oxygenator. Oxygenation was satisfactory in perfusions carried out at normothermia and during hypothermia. During the rewarming phase of hypothermic perfusions hypoxaemia occurred. This could be prevented by a ganglion blocking agent (trimetaphan) given during the cooling phase. arterial, venous, and mixed venous blood respectively. ever, during the studies reported here, the flow rate was kept constant at 2-4 L1/min/M2 body surface area.
Blood oxygenation was studied in patients undergoing cardiopulmonary bypass using the ; Rygg, Frederiksen, and Jorgensen, 1963) . Venous blood from the right atrium or both venae cavae is gravity fed into the oxygenator. Inflow gas consisting of 98% 02 and 2% C02 is delivered to the bubble oxygenator at a flow rate one and a half times the blood flow rate through the circuit. After oxygenation and defoaming the blood is returned to the aorta by an occlusive roller pump. In 12 patients extracorporeal circulation was conducted in our standard hypothermic technique. In a further 10 patients perfusion was performed at normothermia, but in all other aspects the perfusion technique was unchanged.
A further seven patients were perfused using the standard hypothermic perfusion, but in addition these patients received a ganglion-blocking agent (trimetaphan, 25 mg) during the cooling phase. Again the flow rate was kept constant and additional doses of trimetaphan were given if the mean arterial pressure rose above 50 mmHg.
During the course of these studies the manufacturers of the oxygenator made minor changes in the bubbling system. Of our 10 normothermic perfusions, 5 were carried out using the unmodified oxygenator and 5 perfusions were performed using the new oxygenator. The hypothermic perfusions with and without trimetaphan were carried out using the unmodified oxygenator.
Blood samples were obtained from the venous (inflow) and arterial (outflow) ends of the oxygenator. In the hypothermic perfusion blood samples were obtained during established hypothermia and at every 2' C increment in body temperature during the rewarming phase. In the normothermic perfusions blood samples were obtained at 2-minute intervals for the first 10 minutes of perfusion and then at 10-minute intervals.
LABORATORY TECHNIQUES
Blood samples were analysed as soon as possible after withdrawal. All blood samples were analysed at 370 C. Po2 and PCo2
were measured in a combined cuvette instrument (IL Model 113) and pH was determined using the ultra micro pH electrode of the same system. The accuracy of this instrument in our laboratory has been described (Flenley, Millar, and Rees, 1967) . Corrections from the temperature at which the Po , Pco0, and pH were measured to the temperature at which the samples were withdrawn from the oxygenator were made using the data of Severinghaus (1966) . The same data were used to derive oxygen saturations. In a number of cases oxygen saturations were also measured directly using a haemoreflector technique. Oxygen-carrying capacity of the blood was measured using a spectrophotometric technique. In 22 of the 29 patients one determination of total oxygen content was made using the method of Van Slyke and Neill (1924) . This sample was withdrawn at varying temperatures and at the same time a sample was withdrawn for estimation of Po2 and oxygen-carrying capacity. From the oxygen tension and capacity a calculated oxygen content was obtained. Tlhe relationship between calculated oxygen content and measured oxygen content is shown in Figure 1 .
RESULTS
Two patients who had a standard hypothermic perfusion and one patient who had a hypothermic perfusion with trimetaphan had low arterial oxygen tensions even during hypothermia. The results from these patients are shown in Table I but as they were quite different from those of the other patients they have been excluded from further analysis. (Table II) At moderate hypothermia (25 to 320 C) arterial oxygen tensions ranged from 108 to 323 mmHg. These levels of oxygen tensions ensured that in all patients the blood leaving the oxygenator was fully saturated. The mean saturation of the venous blood returned from the patients was 80% and in only one patient was the venous saturation less than 70%. Due to the haemodilution technique the oxygen-carrying capacity of the blood was reduced (mean 11 36+S.E.M. 054 vol.%). (Fig. 2) , and when the rewarming was completed venous oxygen saturation was 56+4%. There had been no significant change in the degree of haemodilution during rewarming so that arteriovenous oxygen difference had nearly doubled. Throughout the perfusion the pump flow rate had been kept constant.
NORMOTHERMIC PERFUSION (Table III) After the start of the perfusion there was an immediate fall in arterial oxygen tensions and saturations in all patients (Fig. 3) (Clowes, 1960) . During our perfusions the plasma haemoglobin increased by approximately 1 mg/100 ml per minute of perfusion. In addition, bubble oxygenators require adequate defoaming devices and the defoaming action may become unreliable in long perfusions (Galletti, 1967) . Rygg et al. (1963) reported that in an in vitro study using ox blood adequate oxygenation occurred with the Rygg-Kyvsgaard bubble oxygenator. The same group also reported its successful use in prolonged extracorporeal circulation . Detailed examination, however, of its in vivo oxygenating capacity was not made. Using a similar bubble oxygenator (Travenol U-130) Burbank, Ferguson, and Burford (1966) performed an in vitro perfusion experiment. They demonstrated that this type of oxygenator could be limited by unusually low oxygen saturation of the venous blood and that the single passage oxygenating capacity was fixed at 35 to 40%. Apart from the three abnormal cases (Table I) , we found that at moderate hypothermia there was always adequate arterial oxygenation. During rewarming arterial oxygen tensions fell and, in a number of patients, the low arterial oxygen tensions at normothermia were associated with arterial oxygen desaturation. As all oxygenation was being supplied by the bubble oxygenator, its function must be regarded as inadequate.
One possibility is that the oxygenator cannot supply the oxygen demands of a patient at normal temperature. Adequate oxygenation was, however, obtained in perfusions undertaken at normothermia, although the time taken to achieve oxygenation was often prolonged. There was a relatively constant relationship between the levels of arterial and venous oxygen saturations with the arterial blood 35% more saturated than 446 Uva group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from the venous blood. In this respect the in vivo performance of the Rygg-Kyvsgaard bubble oxygenerator is similar to the in vitro performance of the Travenol U-130 described by Burbank and his colleagues (1966) . They had predicted from their experimental work that venous blood delivered to the oxygenator with saturations below about 55% would be returned to the patient incompletely oxygenated. It is in such conditions of venous desaturation that we have encountered arterial hypoxia.
Venous desaturation at the start of perfusion is almost invariable. This is presumably due to the low cardiac output at this time which has been noted in animal studies (Cordell, Spencer, and Meredith, 1960; Rowen, Viles, and Ankeney, 1960) . Several factors probably contribute to this low output, including handling of the heart, the presence of cannulae, a degree of blood loss, and the underlying cardiac pathology.
Venous desaturation may also occur during cardiopulmonary bypass due to the addition of stored blood. Our preliminary studies had shown that the addition of 500 ml of stored blood reduced arterial and venous oxygen tensions for a period of 2 to 3 minutes. For this reason blood samples were not taken until at least 5 minutes after the addition of stored blood.
Once adequate perfusion is achieved, venous oxygen saturation does not usually fall below 60% (Clowes, 1960) . Practical experience in many centres has shown that a flow rate of 2-4 L./min/m2 provides adequate oxygenation and that during hypothermia flow rates can be reduced below this level (Clowes, 1967; Cheng, et al., 1959) . In a preliminary study we had altered flow rate with little effect on arterial oxygenation except when the flow rate was severely reduced. This is in agreement with the findings of Paneth and his colleagues (1957) who found in dogs that, provided the flow rate was above 1 2 L./min/m2, oxygen consumption was constant. In addition, within the variation in haematocrit in our patients, there was no association between haematocrit and hypoxia.
During hypothermia venous blood was usually more than 80% saturated; however, in the rewarming period, venous desaturation became marked with levels in some patients below 45%. Theye and Kirklin (1963) , reporting on the performance of a vertical film oxygenator, noted venous oxygen saturations of 79 to 92% at 300 C. During the rewarming phase the venous oxygen saturations of some patients fell below 60%.
Arterial oxygenation, however, was always 2K adequate, presumably because their film oxygenator had sufficient reserve capacity to cope with such desaturated blood.
Our results have shown that perfusion flow rates as assessed by oxygenation were adequate at hypothermia and during normothermic perfusions; however, in the rewarming phase desaturation occurs. It is possible that at this time circulation is being re-established to areas underperfused during the hypothermic period. Alterations in vascular tone occur during cardiopulmonary bypass (Cordell et al., 1960; Sanger et al., 1960) .
These changes could produce regional variations in flow with some areas receiving a reduced flow and being inadequately cooled. The effects of this would not appear until the rewarming period when affected areas would return markedly desaturated blood. If this increased vascular tone could be abolished it should be possible to avoid hypoxia resulting from this cause. We chose to use trimetaphan, a ganglion-blocking agent which has been widely used to produce controlled hypotension in surgery, because of its short duration of action. Those patients treated with trimetaphan showed smaller falls in venous oxygen saturations during rewarming, and arterial desaturation did not occur. The findings of Taguchi and his colleagues (1967) that patients treated with the alpha adrenergic blocking drug, phenoxybenzamine, prior to cardiopulmonary bypass are less likely to develop a metabolic acidosis parallels our work.
It is difficult to explain the failure to produce adequate oxygenation at hypothermia and normothermia in the three patients excluded from the detailed analysis. A possible explanation is that in a small number of oxygenators the bubbling system is faulty but we have no direct proof of this.
